Could this earnings season be the could be the worst quarter since 2009? Here's what Estimize's Christine Short is expecting.» Read More
If you’re saving for retirement and panicked by the volatility in the market, at least one pro questions your Street smarts.
Investors were closely monitoring developments in the attempts to contain Ebola after a new case was diagnosed in New York City.
Ebola screenings at New York City airports will be increased, and one health care worker returning from one of the three Ebola affected countries in West Africa has been quarantined. CNBC's Meg Tirrell has the details.
Special advisor to NY Mayor Bill de Blasio Dr. Irwin Redlener, discusses the role of the CDC as well as the local public health agencies to prepare for a potential Ebola patient.
Special advisor to NY Mayor Bill de Bblasio Dr. Irwin Redlener, provides insight to the preparedness of New York for containing Ebola.
Chris Ailman, CalSTRS CIO, is still sold on the long-term opportunity in Amazon and discusses additional long-term investment opportunities right now.
Discussing recent movement in 401k portfolios on market fears, with Ric Edelman, Edelman Financial Services, and CNBC's Sharon Epperson.
CNBC's Sharon Epperson reports on the correlation between market moves and movement in 401(k) investments.
Discussing the consumer story amid a stronger dollar and lower oil prices, with John Spallanzani, GFI Group; "Fast Money's" Tim Seymour; and Marc Lopresti, Lopresti Law Group.
CNBC's Tyler Mathisen reports a former CNBC colleague Terry Keenan has died. Keenan worked for CNBC between 1995 and 1998 as a reporter and anchor.
Discussing what really moved the bond market one week ago, and what we're hearing from the Fed, with Jeff Rosenberg, BlackRock.
Digging into the market rally, with John Spallanzani, GFI Group.
Discussing current market conditions, and global economic data, with independent investment consultant David Darst and CNBC's Bob Pisani.
According to Dow Jones citing sources familiar, Roku is working on a confidential IPO. CNBC's Dominic Chu has the details.
Ralph Acampora, Altaira senior managing director, and Carter Worth, Sterne Agee, debate the bull and the bear case on the markets.
Medical supply company Edwards Lifesciences is currently the best performer in the S&P 500. CNBC's Dominic Chu outlines some of Friday's biggest movers.
Shire CEO Flemming Ornskov, discusses the company's break up with AbbVie, tax inversion rules, and proceeding as an independent company.
Discussing Ebola protocols and if the U.S. could better improve Ebola detection standards, with missionary nurse and Ebola survivor Nancy Writebol.
Any underperforming company can come under attack from an activist investor. Hedge funds ponder whether Amazon will be targeted next.
Amazon's huge earnings miss may be the last straw for investors.